Development of novel hydrazidoarylaminopyrimidine-based BTK/FLT3 dual inhibitors with potent in vivo anti-hematological malignancies effects
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 5 January 2023 245 Part 1 - Subject
- Language
- ISSN
- 0223-5234